KRAS and neoplasm: EVs can affect the extracellular matrix (ECM) by modulating tumor immune responses and can even transfer active oncogenes, e.g., epidermal growth factor receptor (EGFR) or the mutant form of Kirsten rat sarcoma virus (KRAS) [35,36,37,38].